Cochrane Abstracts
Adalimumab for maintenance of remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adalimumab for Maintenance of Remission in Crohn's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432485/all/Adalimumab_for_maintenance_of_remission_in_Crohn's_disease_New. Accessed 04 December 2023.
Adalimumab for maintenance of remission in Crohn's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432485/all/Adalimumab_for_maintenance_of_remission_in_Crohn's_disease_New. Accessed December 4, 2023.
Adalimumab for maintenance of remission in Crohn's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432485/all/Adalimumab_for_maintenance_of_remission_in_Crohn's_disease_New
Adalimumab for Maintenance of Remission in Crohn's Disease [Internet]. In: Cochrane Abstracts. [cited 2023 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432485/all/Adalimumab_for_maintenance_of_remission_in_Crohn's_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adalimumab for maintenance of remission in Crohn's disease
ID - 432485
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432485/all/Adalimumab_for_maintenance_of_remission_in_Crohn's_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -
